Effects of Soy Isoflavone on Bone Health Among Saudi Female Students Imam Abdulrahman Bin Faisal University.
NCT ID: NCT04547010
Last Updated: 2023-09-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
28 participants
INTERVENTIONAL
2018-12-12
2019-03-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Effectiveness of Soy Phytoestrogens to Prevent Bone Loss
NCT00665860
Soy and Isoflavones Effect on Bone
NCT00668447
Effect of Soy Isoflavones on Bone Mineral Density and Physical Performance Indices
NCT00661856
Soy Isoflavones and Breast Cancer Risk Reduction
NCT00204490
Phase I Clinical Study of Soy Isoflavones in Healthy, Post-Menopausal Women
NCT00491595
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
In four weeks of intervention study the participants instructed to receive (60 mg) of soy-isoflavone supplement per day, after this period the Bone Mineral Density was assessed by Dual X-ray Absorptiometry scan to evaluate the effect of soy-isoflavone supplement on Bone mineral density.
Soy Isoflavone supplement
Participants received 60 mg of soy-isoflavone supplement per day.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Soy Isoflavone supplement
Participants received 60 mg of soy-isoflavone supplement per day.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* University students
* aged between 18-25 years
Exclusion Criteria
18 Years
25 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Imam Abdulrahman Bin Faisal University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tunny Sebastian
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Imam Abdulrahman Bin Faisal University
Dammam, Eastern Province, Saudi Arabia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB-UGS-2018-03-273
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.